Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Double-blind Study of Tisporin vs Restasis in Moderate to Severe Dry Eye Disease
KCT0000619Phase 3Recruiting
- Sponsor
- Hanlim Pharm
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tisporin in dry eye syndrome (DED) (2 arms), sponsored by Hanlim Pharm. Started May 2012; status: recruiting.
02
Drugs
Tisporin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0000619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000619.